DCB-BO1301
- Generic Name
- DCB-BO1301
Safety and Efficacy of DCB-BO1301 in Advanced Melanoma
- First Posted Date
- 2016-12-16
- Last Posted Date
- 2022-03-18
- Lead Sponsor
- Chung Mei Biopharma Co., Ltd
- Target Recruit Count
- 33
- Registration Number
- NCT02994498
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath